For the first time, patients living with a rare neurological disease have a new treatment option — and the FDA’s decision could mark a major moment for the community. Here’s what to know about the newly approved therapy.
Summary from sourceFor the first time, patients living with a rare neurological disease have a new treatment option — and the FDA’s decision could mark a major moment for the community. Here’s what to know about the newly approved therapy.
Summary from source